Home/Filings/4/0001193125-25-291651
4//SEC Filing

ORVILLE JACOB A 4

Accession 0001193125-25-291651

CIK 0001124140other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:30 PM ET

Size

5.7 KB

Accession

0001193125-25-291651

Insider Transaction Report

Form 4
Period: 2025-11-19
ORVILLE JACOB A
EVP, GM, Screening
Transactions
  • Sale

    Common Stock

    2025-11-19$75.00/sh5,000$375,00023,237 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,490
Footnotes (2)
  • [F1]The transaction reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on May 27, 2025.
  • [F2]In addition to the shares of Common Stock reported on this Form 4, which total 24,727 shares, Mr. Orville also holds, in the aggregate, an additional 79,661 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Documents

1 file

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001263312

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:30 PM ET
Size
5.7 KB